Changchun High-Tech (000661.SZ) subsidiary's GenSci161 injection domestic production drug registration clinical trial application accepted

Zhitong Finance APP News: Changchun High-Tech (000661.SZ) has announced that recently, its controlling subsidiary, Changchun GeneScience Pharmaceuticals Co., Ltd. (hereinafter referred to as "GeneScience Pharmaceuticals"), received a Notice of Acceptance approved and issued by the National Medical Products Administration. GeneScience Pharmaceuticals' domestic production drug registration clinical trial application for GenSci161 Injection has been accepted.